Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;173:614–22.
Article
CAS
PubMed
PubMed Central
Google Scholar
Guaraldi G, Stentarelli C, Zona S, Santoro A. A HIV-associated lipodystrophy: impact of antiretroviral therapy. Drugs. 2013;73:1431–50.
Article
CAS
PubMed
Google Scholar
Potthoff A, Brocmeyer NH, Gelbrich G, Neuhaus K, Stefa E, Reinsch N. Lipodystrophy—a sign for metabolic syndrome in patients of the HIV-HEART study. J Dtsch Dermatol Ges. 2010;8:92–8.
Article
PubMed
Google Scholar
Brown T, Wang Z, Chu H, Palela FJ, Kingsley L, Witt MD, et al. Longitudinal anthropometric changes in HIV-infected and HIV-uninfected men. J Acquir Immune Defic Syndr. 2006;43:356–62.
Article
PubMed
Google Scholar
Leclercq P, Dr Goujard CM, Duracinsky M, Allaert F, L’henaff M, Hellet M, et al. High prevalence and impact on the quality of life of facial lipoatrophy and other abnormalities in fat tissue distribution in HIV-infected patients treated with antiretroviral therapy. AIDS Res Hum Retroviruses. 2013;29:761–8.
Article
CAS
PubMed
Google Scholar
Savès M, Raffi F, Capeau J, Rozenbaum W, Ragnaud JM, Perronne C, et al. Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy. Clin Infect Dis. 2002;34:1396–405.
Article
PubMed
Google Scholar
Freitas P, Santos AC, Carvalho D, Pereira J, Marques R, Martinez E, et al. Fat mass ratio: an objective tool to define lipodystrophy in HIV-infected patients under antiretroviral therapy. J Clin Densitom. 2010;13:197–203.
Article
PubMed
Google Scholar
Mercier S, Gueye NF, Cournil A, Fontbonne A, Copin N, Ndiaye I, et al. Lipodystrophy and metabolic disorders in HIV-1-infected adults on 4- to 9-year antiretroviral therapy in Senegal: a case–control study. J Acquir Immune Defic Syndr. 2009;51:224–30.
Article
PubMed
Google Scholar
Carr A, Emery S, Law M, Puls R, Lundgren JD, Powderly WG. An objective case definition of lipodystrophy in HIV-infected adults: a case–control study. Lancet. 2003;361:726–35.
Article
CAS
PubMed
Google Scholar
Lake JE, Wohl D, Scherzer R, Grunfeld C, Tien PC, Sidney S, et al. Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study. AIDS Care. 2011;23:929–38.
Article
PubMed
PubMed Central
Google Scholar
Bacchetti P, Gripshover B, Grunfeld C, Heymsfield S, McCreath H, Osmond D, et al. Fat distribution in men with HIV infection. J Acquir Immune Defic Syndr. 2005;40:121–31.
Article
PubMed
Google Scholar
Jantarapakde J, Phanuphak N, Chaturawit C, Pengnonyang S, Mathajittiphan P, Takamtha P, et al. Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults. AIDS Patient Care STDS. 2014;28:331–40.
Article
PubMed
Google Scholar
Saint-Marc T, Partisani M, Poizot-Martin I, Rouviere O, Bruno F, Avellaneda R, et al. Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study. AIDS. 2000;14:37–49.
Article
CAS
PubMed
Google Scholar
Ioannidis JP, Trikalinos TA, Law M, Carr A, HIV Lipodystrophy Case Definition Study Group. HIV lipodystrophy case definition using artificial neural network modelling. Antivir Ther. 2003;8:435–41.
PubMed
Google Scholar
Cabrero E, Griffa L, Burgos A, HIV Body Physical Changes Study Group. Prevalence and impact of body physical changes in HIV patients treated with highly active antiretroviral therapy: results from a study on patient and physician perceptions. AIDS Patient Care STDS. 2010;24:5–13.
Article
PubMed
Google Scholar
Heath KV, Hogg RS, Singer J, Chan KJ, O’Shaughnessy MV, Montaner JS. Antiretroviral treatment patterns and incident HIV-associated morphologic and lipid abnormalities in a population-based chort. J Acquir Immune Defic Syndr. 2002;30:440–7.
Article
CAS
PubMed
Google Scholar
Mutimura E, Stewart A, Rheeder P, Crowther NJ. Metabolic function and the prevalence of lipodystrophy in a population of HIV-infected African subjects receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2007;46:451–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lichtenstein KA, Ward DJ, Moorman AC, Delaney KM, Young B, Palella FJ Jr, et al. Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS. 2001;15:1389–98.
Article
CAS
PubMed
Google Scholar
Palella FJ Jr, Cole SR, Chmiel JS, Riddler SA, Visscher B, Dobs A, et al. Anthropometrics and examiner-reported body habitus abnormalities in the multicenter AIDS cohort study. Clin Infect Dis. 2004;38:903–7.
Article
PubMed
Google Scholar
Barcellos NT, Fuchs SC, Fuchs FD. Prevalence of and risk factors for HIV infection in individuals testing for HIV at counseling centers in Brazil. Sex Transm Dis. 2003;30:166–73.
Article
PubMed
Google Scholar
Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet. 1999;353:2093–9.
Article
CAS
PubMed
Google Scholar
Tien PC, Grunfeld C. What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection. Curr Opin Infect Dis. 2004;17:27–32.
Article
PubMed
Google Scholar
Alberti KG, Zimmet P, Shaw J. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366:1059–62.
Article
PubMed
Google Scholar
Fields-Gardner C. HIV and AIDS. In: Nelms M, Sucher K, Long S, editors. Nutrition therapy and pathophysiology. Belmont: Thomson/Brooks-Cole; 2007. p. 805–42.
Google Scholar
Santos CP, Felipe YX, Braga PE, Ramos D, Lima RO, Segurado AC. Self-perception of body changes in persons living with HIV/AIDS: prevalence and associated factors. AIDS. 2005;19:14–21.
Article
Google Scholar
Iwuala SO, Lesi OA, Fasanmade OA, Sabir AA, Olamoyegun MA, Okany CC. Prevalence of and risk factors for lipoatrophy in patients with HIV infection in Nigeria. AIDS Res Treat. 2015;2015:402638.
PubMed
PubMed Central
Google Scholar
Tien PC, Benson C, Zolopa AR, Sidney S, Osmond D, Grunfeld C. The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics. Am J Epidemiol. 2006;163:860–9.
Article
PubMed
PubMed Central
Google Scholar
Tien PC, Cole SR, Williams CM, Li R, Justman JE, Cohen MH, et al. Incidence of lipoatrophy and lipohypertrophy in the women’s interagency HIV study. J Acquir Immune Defic Syndr. 2003;34:461–6.
Article
PubMed
Google Scholar
de Waal R, Cohen K, Maartens G. Systematic review of antiretroviral-associated lipodystrophy: lipoatrophy, but not central fat gain, is an antiretroviral adverse drug reaction. PLoS ONE. 2013;8:e63623.
Article
PubMed
PubMed Central
Google Scholar
Finkelstein JL, Gala P, Rochford R, Glesby MJ, Mehta S. HIV/AIDS and lipodystrophy: implications for clinical management in resource-limited settings. J Int AIDS Soc. 2015;18:19033.
Article
PubMed
PubMed Central
Google Scholar
Mallon PW, Miller J, Cooper DA, Carr A. Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy. AIDS. 2003;17:971–9.
Article
CAS
PubMed
Google Scholar